Roles of Eicosanoids in Prostate Cancer

Overview

Journal Future Lipidol

Publisher Future Medicine

Date 2014 Feb 25

PMID 24563660

Citations 6

Authors

Kasem Nithipatikom

William B Campbell

Affiliations

Soon will be listed here.

Abstract

Eicosanoids, the metabolites of arachidonic acid, have diverse functions in the regulation of cancer including prostate cancer. This review will provide an overview of the roles of eicosanoids and endocannabinoids and their potential as therapeutic targets for prostate cancer treatment.

Citing Articles

A Multi-Level Systems Biology Analysis of Aldrin's Metabolic Effects on Prostate Cancer Cells.

Bedia C, Dalmau N, Nielsen L, Tauler R, Marin de Mas I Proteomes. 2023; 11(2).

PMID: 37092452 PMC: 10123692. DOI: 10.3390/proteomes11020011.

Anti-inflammatory Property of AMP-activated Protein Kinase.

Noor H, Mou N, Salem L, Shimul M, Biswas S, Akther R Antiinflamm Antiallergy Agents Med Chem. 2019; 19(1):2-41.

PMID: 31530260 PMC: 7460777. DOI: 10.2174/1871523018666190830100022.

Application of Docking Analysis in the Prediction and Biological Evaluation of the Lipoxygenase Inhibitory Action of Thiazolyl Derivatives of Mycophenolic Acid.

Tsolaki E, Eleftheriou P, Kartsev V, Geronikaki A, Saxena A Molecules. 2018; 23(7).

PMID: 29970872 PMC: 6099768. DOI: 10.3390/molecules23071621.

Metabolic alterations in urine extracellular vesicles are associated to prostate cancer pathogenesis and progression.

Clos-Garcia M, Loizaga-Iriarte A, Zuniga-Garcia P, Sanchez-Mosquera P, Cortazar A, Gonzalez E J Extracell Vesicles. 2018; 7(1):1470442.

PMID: 29760869 PMC: 5944373. DOI: 10.1080/20013078.2018.1470442.

EP4 as a Therapeutic Target for Aggressive Human Breast Cancer.

Majumder M, Nandi P, Omar A, Ugwuagbo K, Lala P Int J Mol Sci. 2018; 19(4).

PMID: 29596308 PMC: 5979567. DOI: 10.3390/ijms19041019.

References

Tjandrawinata R, Hughes-Fulford M . Up-regulation of cyclooxygenase-2 by product-prostaglandin E2. Adv Exp Med Biol. 1997; 407:163-70. DOI: 10.1007/978-1-4899-1813-0_25. View

Kelavkar U, Cohen C, Kamitani H, Eling T, Badr K . Concordant induction of 15-lipoxygenase-1 and mutant p53 expression in human prostate adenocarcinoma: correlation with Gleason staging. Carcinogenesis. 2000; 21(10):1777-87. DOI: 10.1093/carcin/21.10.1777. View

Swami S, Krishnan A, Moreno J, Bhattacharyya R, Peehl D, Feldman D . Calcitriol and genistein actions to inhibit the prostaglandin pathway: potential combination therapy to treat prostate cancer. J Nutr. 2006; 137(1 Suppl):205S-210S. DOI: 10.1093/jn/137.1.205S. View

Madaan S, Abel P, Chaudhary K, Hewitt R, Stott M, Stamp G . Cytoplasmic induction and over-expression of cyclooxygenase-2 in human prostate cancer: implications for prevention and treatment. BJU Int. 2000; 86(6):736-41. DOI: 10.1046/j.1464-410x.2000.00867.x. View

Hanus L, Fride E, Breuer A, Vogel Z, Shalev D, Kustanovich I . 2-arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor. Proc Natl Acad Sci U S A. 2001; 98(7):3662-5. PMC: 31108. DOI: 10.1073/pnas.061029898. View

Laine K, Jarvinen K, Mechoulam R, Breuer A, Jarvinen T . Comparison of the enzymatic stability and intraocular pressure effects of 2-arachidonylglycerol and noladin ether, a novel putative endocannabinoid. Invest Ophthalmol Vis Sci. 2002; 43(10):3216-22. View

London S, Daly A, Leathart J, Navidi W, Idle J . Lung cancer risk in relation to the CYP2C9*1/CYP2C9*2 genetic polymorphism among African-Americans and Caucasians in Los Angeles County, California. Pharmacogenetics. 1996; 6(6):527-33. DOI: 10.1097/00008571-199612000-00006. View

Fujino H, Regan J . Prostanoid receptors and phosphatidylinositol 3-kinase: a pathway to cancer?. Trends Pharmacol Sci. 2003; 24(7):335-40. DOI: 10.1016/S0165-6147(03)00162-7. View

Patel M, Subbaramaiah K, Du B, Chang M, Yang P, Newman R . Celecoxib inhibits prostate cancer growth: evidence of a cyclooxygenase-2-independent mechanism. Clin Cancer Res. 2005; 11(5):1999-2007. DOI: 10.1158/1078-0432.CCR-04-1877. View

10.

Uotila P, Valve E, Martikainen P, Nevalainen M, Nurmi M, Harkonen P . Increased expression of cyclooxygenase-2 and nitric oxide synthase-2 in human prostate cancer. Urol Res. 2001; 29(1):23-8. DOI: 10.1007/s002400000148. View

11.

Izzo A, Aviello G, Petrosino S, Orlando P, Marsicano G, Lutz B . Increased endocannabinoid levels reduce the development of precancerous lesions in the mouse colon. J Mol Med (Berl). 2007; 86(1):89-98. PMC: 2755791. DOI: 10.1007/s00109-007-0248-4. View

12.

Pidgeon G, Tang K, Cai Y, Piasentin E, Honn K . Overexpression of platelet-type 12-lipoxygenase promotes tumor cell survival by enhancing alpha(v)beta(3) and alpha(v)beta(5) integrin expression. Cancer Res. 2003; 63(14):4258-67. View

13.

Lee L, Pan C, Cheng C, Chi C, Liu T . Expression of cyclooxygenase-2 in prostate adenocarcinoma and benign prostatic hyperplasia. Anticancer Res. 2001; 21(2B):1291-4. View

14.

Schirner M, Schneider M . The prostacyclin analogue cicaprost inhibits metastasis of tumours of R 3327 MAT Lu prostate carcinoma and SMT 2A mammary carcinoma. J Cancer Res Clin Oncol. 1992; 118(7):497-501. DOI: 10.1007/BF01225263. View

15.

Mimeault M, Pommery N, Wattez N, Bailly C, Henichart J . Anti-proliferative and apoptotic effects of anandamide in human prostatic cancer cell lines: implication of epidermal growth factor receptor down-regulation and ceramide production. Prostate. 2003; 56(1):1-12. DOI: 10.1002/pros.10190. View

16.

Timar J, Raso E, Dome B, Li L, Grignon D, Nie D . Expression, subcellular localization and putative function of platelet-type 12-lipoxygenase in human prostate cancer cell lines of different metastatic potential. Int J Cancer. 2000; 87(1):37-43. DOI: 10.1002/1097-0215(20000701)87:1<37::aid-ijc6>3.0.co;2-l. View

17.

Ghosh J . Rapid induction of apoptosis in prostate cancer cells by selenium: reversal by metabolites of arachidonate 5-lipoxygenase. Biochem Biophys Res Commun. 2004; 315(3):624-35. DOI: 10.1016/j.bbrc.2004.01.100. View

18.

Moreno J, Krishnan A, Swami S, Nonn L, Peehl D, Feldman D . Regulation of prostaglandin metabolism by calcitriol attenuates growth stimulation in prostate cancer cells. Cancer Res. 2005; 65(17):7917-25. DOI: 10.1158/0008-5472.CAN-05-1435. View

19.

Hussain T, Gupta S, Mukhtar H . Cyclooxygenase-2 and prostate carcinogenesis. Cancer Lett. 2003; 191(2):125-35. DOI: 10.1016/s0304-3835(02)00524-4. View

20.

Jones S, Howl J . Cannabinoid receptor systems: therapeutic targets for tumour intervention. Expert Opin Ther Targets. 2003; 7(6):749-58. DOI: 10.1517/14728222.7.6.749. View